MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Cash from Investing Activities of -$1.1 million for Q4 2025, up 10.59% on a YoY basis from -$984708.2 in Q4 2024, and down 99.09% quarter-over-quarter from -$547000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Cash from Investing Activities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Cash from Investing Activities for 9 years, with the latest figure at -$1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 10.59% year-over-year to -$1.1 million; the trailing twelve-month figure through Dec 2025 stood at -$4.1 million (down 117.49% YoY), and the FY2025 full-year result was -$4.1 million, down 117.49% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$1.1 million, down from -$547000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $51.2 million in Q4 2023, with the low at -$25.4 million in Q4 2021.
- Historically, Cash from Investing Activities has averaged -$2.7 million across 5 years, with a median of -$4.3 million in 2023.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities sank 367.49% — and 2023, when it jumped 702.66%.
- MeiraGTx Holdings' Cash from Investing Activities stood at -$25.4 million in 2021, then soared by 66.53% to -$8.5 million in 2022, then jumped by 702.66% to $51.2 million in 2023, then plunged by 102.38% to -$1.2 million in 2024, then climbed by 10.59% to -$1.1 million in 2025.
- The last three Cash from Investing Activities figures came in at -$1.1 million (Q4 2025), -$547000.0 (Q3 2025), and -$761000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | -1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -547,000.00 |
| Sep 30, 2025 | -547,000.00 |
| Jun 30, 2025 | -761,000.00 |
| Jun 30, 2025 | -761,000.00 |
| Mar 31, 2025 | -1.71 Mn |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -1.31 Mn |
| Sep 30, 2024 | -1.31 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Mar 31, 2024 | 27.34 Mn |
| Mar 31, 2024 | 27.34 Mn |
| Dec 31, 2023 | 51.18 Mn |
| Dec 31, 2023 | 51.18 Mn |
| Sep 30, 2023 | -3.56 Mn |
| Sep 30, 2023 | -3.56 Mn |